In this podcast episode, the Oncology Brothers (Drs. Rohit & Rahul Gosain) are joined by Dr. Tanios Bekaii-Saab, Mayo Clinic Comprehensive Cancer Center, to discuss the MOUNTAINEER Phase II study, which prompted the FDA approval of tucatinib in combination with trastuzumab in treating advanced colorectal cancer HER2 positive patients.